Researcher
Lisa Moris
- Disciplines:Endocrinology and metabolic diseases, Urology and nephrology
Affiliations
- Laboratory of Molecular Endocrinology (Division)
Member
From1 Aug 2016 → 31 Dec 2019
Publications
1 - 10 of 42 results
- A systematic review on the impact of surgeon and hospital caseload volume on oncological and non-oncological outcomes after radical prostatectomy for non-metastatic prostate cancer(2021)
Authors: T Van den Broeck, D Oprea-Lager, Lisa Moris, M Kailavasan, E Briers, P Cornford, M De Santis, G Gandaglia, Gillessen S Sommer, JP Grummet, et al.
Pages: S471 - S472Number of pages: 2 - A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research(2021)
Authors: Anthony S Bates, Jennifer Ayers, Nikolaos Kostakopoulos, Thomas Lumsden, Ivo G Schoots, Peter-Paul M Willemse, Yuhong Yuan, Roderick CN van den Bergh, Jeremy P Grummet, Henk G van der Poel, et al.
Pages: 405 - 423Number of pages: 19 - Evaluation of oncological outcomes and data quality in studies assessing nerve sparing versus non-nerve sparing radical prostatectomy in non-metastatic prostate cancer: A systematic review(2021)
Authors: Lisa Moris, G Gandaglia, A Vilaseca, T Van den Broeck, E Briers, M De Santis, S Gillessen, N Grivas, A Henry, TB Lam, et al.
Pages: S426 - S427Number of pages: 2 - EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent(2021)
Authors: Nicolas Mottet, Roderick CN van den Bergh, Erik Briers, Thomas Van den Broeck, Marcus G Cumberbatch, Maria De Santis, Stefano Fanti, Nicola Fossati, Giorgio Gandaglia, Silke Gillessen, et al.
Pages: 243 - 262Number of pages: 20 - EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer(2021)
Authors: Philip Cornford, Roderick CN van den Bergh, Erik Briers, Thomas Van den Broeck, Marcus G Cumberbatch, Maria De Santis, Stefano Fanti, Nicola Fossati, Giorgio Gandaglia, Silke Gillessen, et al.
Pages: 263 - 282Number of pages: 20 - Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol(2021)
Authors: Katharina Beyer, Lisa Moris, Michael Lardas, Anna Haire, Francesco Barletta, Simone Scuderi, Eleni Vradi, Giorgio Gandaglia, Muhammad Imran Omar, Steven MacLennan, et al.
Number of pages: 5 - Current and emerging therapies for localized high-risk prostate cancer(2020)
Authors: Lisa Moris, Gaëtan Devos, Thomas Van den Broeck, Daimantas Milonas, Maarten Albersen, Charlien Berghen, Gert De Meerleer, Wout Devlies, Wouter Everaerts, Thomas Gevaert, et al.
Pages: 267 - 282Number of pages: 16 - Comparison of postoperative complications of ileal conduits versus orthotopic neobladders(2020)
Authors: Liesbeth Demaegd, Maarten Albersen, Tim Muilwijk, Uros Milenkovic, Lisa Moris, Wouter Everaerts, Hendrik Van Poppel, Frank Van der Aa, Steven Joniau, Murat Akand
Pages: 2541 - 2554Number of pages: 14 - Reply to Francesco Montorsi, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27(2020)
Authors: Lisa Moris, Nicolas Mottet, Thomas Wiegel
Pages: E193 - E194Number of pages: 2 - Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer(2020)
Authors: Wout Devlies, Markus Eckstein, Alessia Cimadamore, Gaëtan Devos, Lisa Moris, Thomas van den Broeck, Rodolfo Montironi, Steven Joniau, Frank Claessens, Thomas Gevaert
Number of pages: 13